GTPase-Activating Protein

general

Centers

Active Trials

$2.3B

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive	14	—

Top Centers for GTPase-Activating Protein(16)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	—	$3M	83.8
2	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	—	$2M	66.2
3	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive		—	$472M	—
4	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		—	$375M	—
5	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive		—	$276M	—
6	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive		—	$222M	—
7	Hollings Cancer CenterCharleston, SC NCI Clinical		—	$187M	—
8	Medical College of Wisconsin Cancer CenterMilwaukee, WI		—	$181M	—
9	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical		—	$143M	—
10	University of Illinois Cancer CenterChicago, IL		—	$122M	—
11	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	$116M	—
12	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX		—	$83M	—
13	Cancer Center at IllinoisUrbana, IL		—	$81M	—
14	University of Cincinnati Cancer CenterCincinnati, OH		—	$71M	—
15	Princess Margaret Cancer CentreToronto, ON		—	—	—
16	Louisiana Cancer Research CenterNew Orleans, LA		—	—	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →